Chembio Diagnostics Inc (CEMI) Inventory Turnover Ratio, from fourth quarter 2022 to fourth quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Chembio Diagnostics Inc   (NASDAQ: CEMI)
 

Chembio Diagnostics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Chembio Diagnostics Inc 's inventory turnover ratio, the ratio that measures Chembio Diagnostics Inc 's ability to manage its supply chain, sequentially decreased to 3.92 in the fourth quarter 2022, but it does not raise any concerns as Chembio Diagnostics Inc continue to execute well, and the inventory turnover ratio remains above the average. Chembio Diagnostics Inc 's average inventory processing period in the Dec 31 2022 quarter, has increased to 93 days, from 78 days, in the Sep 30 2022 quarter.

Within Healthcare sector 117 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 854 in the third quarter 2022, to 1041.

CEMI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Chembio Diagnostics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEMI Inventory Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Inventory Growth -40.29 % -49.63 % -28.06 % -19.38 % 3.23 %
Y / Y Cost of Sales Growth -70.49 % 22.22 % 100.18 % 329.03 % 198.74 %
Inventory Turnover Ratio (TTM) 3.92 4.67 3.8 3.22 2.29
CEMI's Total Ranking # 1041 # 854 # 1139 # 1223 # 1664
Average inventory processing period 93 78 96 113 159
Seq. Inventory Growth -8.86 % -25.14 % -4.52 % -8.33 % -23.12 %
Seq. Cost of Sales Growth -41.93 % 19.44 % -46.88 % -19.89 % 140.48 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 41
Healthcare Sector # 118
Overall Market # 1041

Inventory Turnover Ratio Statistics
High Average Low
5.5 3.42 1.46
(Mar 31 2013)   (Sep 30 2021)



CEMI Company Profile >> Back to CEMI Efficiency Comparisons >> Compare CEMI Inventory Turnover Ratio to its Competitors

Financial Statements
Chembio Diagnostics Inc 's Inventories $ 8 Millions Visit CEMI's Balance sheet
Chembio Diagnostics Inc 's Cost of Revenues TTM $ 39 Millions Visit CEMI's Income Statement
What are CEMI's Sales? Visit CEMI's Sales by Segment

Other Inventory Turnover Ratios
Chembio Diagnostics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CEMI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CEMI's Competitors
Inventory Turnover Ratio for CEMI's Suppliers
Inventory Turnover Ratio for CEMI's Customers

You may also want to know
CEMI's Sales Growth Rates CEMI's Pe Price to earnings ratio CEMI's Receivables Turnover Ratio CEMI's Stock Quote
CEMI's Net Income Growth Rates CEMI's Ps Price to Sales ratio CEMI's Sales per Employee CEMI's Asset Turnover Ratio
CEMI's Net Margin CEMI's Pb Price to Book ratio CEMI's Financial Strength Ratios CEMI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2022 Inventories at quarter ending Dec 31 2022
Natera Inc   13.74 $ 451.016  Millions$ 33  Millions
Rvl Pharmaceuticals Plc  13.65 $ 9.456  Millions$ 1  Millions
Option Care Health Inc   13.54 $ 3,077.817  Millions$ 227  Millions
Eton Pharmaceuticals Inc   13.34 $ 6.933  Millions$ 1  Millions
Rockwell Medical inc   12.25 $ 65.973  Millions$ 5  Millions
Teladoc Health Inc   12.07 $ 743.987  Millions$ 62  Millions
Prophase Labs Inc   11.50 $ 51.993  Millions$ 5  Millions
Myriad Genetics Inc   11.43 $ 202.000  Millions$ 18  Millions
Sotera Health Company  11.19 $ 446.683  Millions$ 40  Millions
Invitae Corporation  10.92 $ 417.256  Millions$ 38  Millions
Precipio inc   10.89 $ 6.902  Millions$ 1  Millions
Sunlink Health Systems Inc   10.88 $ 19.905  Millions$ 2  Millions
Hutchmed china Limited  10.62 $ 311.103  Millions$ 29  Millions
Dermtech Inc   10.38 $ 13.871  Millions$ 1  Millions
Infusystem Holdings Inc  10.27 $ 47.343  Millions$ 5  Millions
Lantheus Holdings Inc   10.21 $ 353.358  Millions$ 35  Millions
Zai Lab Limited  9.89 $ 74.018  Millions$ 7  Millions
Cryo cell International Inc   9.85 $ 8.792  Millions$ 1  Millions
Castle Biosciences Inc   9.49 $ 32.009  Millions$ 3  Millions
Puma Biotechnology Inc   9.21 $ 55.093  Millions$ 6  Millions
Irhythm Holdings Inc   9.16 $ 129.289  Millions$ 14  Millions
Nabriva Therapeutics Plc  9.02 $ 28.581  Millions$ 3  Millions
Qhslab Inc   9.00 $ 0.624  Millions$ 0  Millions
Dmk Pharmaceuticals Corporation  8.83 $ 6.187  Millions$ 1  Millions
Charles River Laboratories International inc   8.61 $ 2,143.318  Millions$ 249  Millions
Camp4 Therapeutics Corporation  8.53 $ 175.498  Millions$ 21  Millions
Cardiff Lexington Corporation  8.25 $ 4.457  Millions$ 1  Millions
Semler Scientific inc   8.10 $ 4.252  Millions$ 1  Millions
Genedx Holdings Corp   7.70 $ 261.444  Millions$ 34  Millions
Opko Health Inc   7.65 $ 627.548  Millions$ 82  Millions

Date modified: 2026-09-08T15:10:53+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.